Cargando…
A promoter mutation in the haemagglutinin segment of influenza A virus generates an effective candidate live attenuated vaccine
BACKGROUND: Annual seasonal and pandemic influenza vaccines need to be produced in a very tight time frame. Haemagglutinin (HA) is the major immunogenic component of influenza vaccines, and there is a lot of interest in improving candidate vaccine viruses. OBJECTIVES: It has been shown elsewhere tha...
Autores principales: | Harvey, Ruth, Johnson, Rachel E, MacLellan-Gibson, Kirsty, Robertson, James S, Engelhardt, Othmar G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262274/ https://www.ncbi.nlm.nih.gov/pubmed/25087607 http://dx.doi.org/10.1111/irv.12274 |
Ejemplares similares
-
Permissible Variation in the 3′ Non-Coding Region of the Haemagglutinin Genome Segment of the H5N1 Candidate Influenza Vaccine Cirus NIBRG-14
por: Johnson, Rachel E., et al.
Publicado: (2012) -
Correction: Permissible Variation in the 3′ Non-Coding Region of the Haemagglutinin Genome Segment of the H5N1 Candidate Influenza Vaccine Cirus NIBRG-14
por: Johnson, Rachel E., et al.
Publicado: (2012) -
Chimeric influenza haemagglutinins: Generation and use in pseudotype neutralization assays
por: Ferrara, Francesca, et al.
Publicado: (2016) -
Evaluation of Haemagglutinin Content by RP-HPLC to Generate Pandemic Influenza Vaccine
por: Kang, Hyunkyung, et al.
Publicado: (2016) -
Developing Vaccines to Combat Pandemic Influenza
por: Robertson, James S., et al.
Publicado: (2010)